Protective effect of chitin oligosaccharides against lipopolysaccharide-induced inflammatory response in BV-2 microglia

Cellular Immunology

Volumn 277, Issue 1-2, 2012, Pages 14-21

  Vo, Thanh Sang ^a   Ngo, Dai Hung ^a   Ta, Quang Van ^a   Wijesekara, Isuru ^a   Kong, Chang Suk ^b   Kim, Se Kwon ^a  

^a Pukyong National University   (South Korea)

^b Silla University   (South Korea)

Author keywords

Chitin oligosaccharides; Cyclooxygenase 2; Lipopolysaccharide; Microglia; Nuclear factor B

Indexed keywords

CHITIN OLIGOSACCHARIDE; CYCLOOXYGENASE 2; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OLIGOSACCHARIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; ENZYME PHOSPHORYLATION; MICROGLIA; MOLECULAR WEIGHT; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE; CHITIN; CYCLOOXYGENASE 2; CYTOKINES; DINOPROSTONE; GENE EXPRESSION REGULATION; I-KAPPA B PROTEINS; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II;

MURINAE;

EID: 84864321795     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.06.005     Document Type: Article

References (39)

1. D.L. Krause, N. Müller, Neuroinflammation, microglia and implications for anti-inflammatory treatment in Alzheimer's disease, Int. J. Alzheimers Dis. (2010). doi:10.4061/2010/732806.
2. Dheen S.T., Kaur C., Ling E.A. Microglial activation and its implications in the brain diseases. Curr. Med. Chem. 2007, 14:1189-1197.
3. Rock R.B., Gekker G., Hu S., Sheng W.S., Cheeran M., Lokensgard J.R., Peterson P.K. Role of microglia in central nervous system infections. Clin. Microbiol. Rev. 2004, 17:942-964.
4. Liu B., Hong J.S. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J. Pharmacol. Exp. Ther. 2003, 304:1-7.
5. D. Trudler, D. Farfara, D. Frenkel, Toll-like receptors expression and signaling in glia cells in neuro-amyloidogenic diseases: towards future therapeutic application, Mediat. Inflamm. (2010). doi:10.1155/2010/497987.
6. Wilms H., Rosenstiel P., Sievers J., Deuschl G., Zecca L., Lucius R. Activation of microglia by human neuromelanin is NF-κB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease. FASEB J. 2003, 17:500-502.
7. Eikelenboom P., van Gool W.A. Neuroinflammatory perspectives on the two faces of Alzheimer's disease. J. Neural Transm. 2004, 111:281-294.
8. Park B.K., Kim M.M. Applications of chitin and its derivatives in biological medicine. Int. J. Mol. Sci. 2010, 11:5152-5164.
9. Ravi Kumar M.N.V. A review of chitin and chitosan applications. React. Funct. Polym. 2000, 46:1-27.
10. Jung W.J., Souleimanov A., Park R.D., Smith D.L. Enzymatic production of N-acetyl chitooligosaccharides by crude enzyme derived from Paenibacillus illioisensis KJA-424. Carbohydr. Polym. 2007, 67:256-259.
11. Ngo D.N., Lee S.H., Kim M.M., Kim S.K. Production of chitin oligosaccharides with different molecular weights and their antioxidant effect in RAW 264.7 cells. J. Funct. Food 2009, 1:188-198.
12. Ngo D.N., Kim M.M., Kim S.K. Chitin oligosaccharides inhibit oxidative stress in live cells. Carbohydr. Polym. 2008, 74:228-234.
13. Wang S.L., Lin H.T., Liang T.W., Chen Y.J., Yen Y.H., Guo S.P. Reclamation of chitinous materials by bromelain for the preparation of antitumor and antifungal materials. Bioresour. Technol. 2008, 99:4386-4393.
14. + when the Griess reaction is used to assay for nitrate. Anal. Biochem. 1995, 224:502-508.
15. Ma Q., Kinneer K., Ye J., Chen B.J. Inhibition of nuclear factor κB by phenolic antioxidants: interplay between antioxidant signaling and inflammatory cytokine expression. Mol. Pharmacol. 2003, 64:211-219.
16. Heo S.J., Yoon W.J., Kim K.N., Ahn G.N., Kang S.M., Kang D.H., Affan A., Oh C., Jung W.K., Jeon Y.J. Evaluation of anti-inflammatory effect of fucoxanthin isolated from brown algae in lipopolysaccharide-stimulated RAW 264.7 macrophages. Food Chem. Toxicol. 2010, 48:2045-2051.
17. Victor V.M., Rocha M., Esplugues J.V., De la Fuente M. Role of free radicals in sepsis: antioxidant therapy. J. Curr. Pharm. Res. 2005, 11:3141-3158.
18. Banati R.B., Gehrmann J., Schubert P., Kreutzberg G.W. Cytotoxicity of microglia. Glia 1993, 7:111-118.
19. Liu B., Gao H.M., Wang J.Y., Jeohn G.H., Cooper C.L., Hong J.S. Role of nitric oxide in inflammation-mediated neurodegeneration. Ann. N.Y. Acad. Sci. 2002, 962:318-331.
20. 2 signaling for neurologic disease. Curr. Med. Chem. 2008, 15:1863-1869.
21. Lee H., Kim Y.O., Kim H., Kim S.Y., Noh H.S., Kang S.S., Cho G.J., Choi W.S., Suk K. Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB J. 2003, 17:1943-1944.
22. Teismann P., Ferger B. Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease. Synapse 2001, 39:167-174.
23. Mrak R.E., Griffin W.S. Glia and their cytokines in progression of neurodegeneration. Neurobiol. Aging 2005, 26:349-354.
24. Van Eldik L.J., Thompson W.L., Ralay Ranaivo H., Behanna H.A., Martin Watterson D. Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approaches. Int. Rev. Neurobiol. 2007, 82:277-296.
25. Marcus J.S., Karackattu S.L., Fleegal M.A., Sumners C. Cytokine-stimulated inducible nitric oxide synthase expression in astroglia: role of Erk mitogenactivated protein kinase and NF-kappaB. Glia 2003, 41:152-160.
26. Krady J.K., Basu A., Allen C.M., Xu Y., LaNoue K.F., Gardner T.W., Levison S.W. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 2005, 54:1559-1565.
27. Barnes P.J., Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 1997, 336:1066-1071.
28. Takatsuna H., Morita S., Nagatsu T., Sawada M., Umezawa K. Inhibition of inflammatory cytokine secretion from mouse microglia cells by DHMEQ, an NF-κB inhibitor. Biomed. Pharmacother. 2005, 59:318-322.
29. Nakajima K., Matsushita Y., Tohyama Y., Kohsaka S., Kurihara T. Differential suppression of endotoxin-inducible inflammatory cytokines by nuclear factor kappa B (NF-κB) inhibitor in rat microglia. Neurosci. Lett. 2006, 401:199-202.
30. Oh Y.T., Lee J.Y., Lee J., Lee J.H., Kim J.E., Ha J., Kang I. Oleamide suppresses lipopolysaccharide-induced expression of iNOS and COX-2 through inhibition of NF-kappaB activation in BV-2 murine microglial cells. Neurosci. Lett. 2010, 474:148-153.
31. Meyer C.F., Wang X., Chang C., Templeton D., Tan T.H. Interaction between c-Rel and the mitogen-activated protein kinase kinase kinase 1 signaling cascade in mediating kappaB enhancer activation. J. Biol. Chem. 1996, 271:8971-8976.
32. 2 release by suppressing the activity of NF-kappaB and JNK in LPS-treated microglia. J. Neurochem. 2008, 107:779-788.
33. Karunakaran S., Ravindranath V. Activation of p38 MAPK in the substantia nigra leads to nuclear translocation of NF-kappaB in MPTP-treated mice. Implication in Parkinson's disease. J. Neurochem. 2009, 109:1791-1799.
34. Kaminska B., Gozdz A., Zawadzka M., Ellert-Miklaszewska A., Lipko M. MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target. Anat. Rec. 2009, 292:1902-1913.
35. Hakim J. Reactive oxygen species and inflammation. C. R. Seances Soc. Biol. Fil. 1993, 187:286-295.
36. Romay C., Armesto J., Remirez D., González R., Ledon N., García I. Antioxidant and anti-inflammatory properties of C-phycocyanin from blue-green algae. Inflamm. Res. 1998, 47:36-41.
37. Fernandes E., Costa D., Toste S.A., Lima J.L., Reis S. In vitro scavenging activity for reactive oxygen and nitrogen species by nonsteroidal anti-inflammatory indole, pyrrole, and oxazole derivative drugs. Free Radical Biol. Med. 2004, 37:1895-1905.
38. Abreu P., Matthew S., González T., Costa D., Segundo M.A., Fernandes E. Anti-inflammatory and antioxidant activity of a medicinal tincture from Pedilanthus tithymaloides. Life Sci. 2006, 78:1578-1585.
39. Kim S.H., Lim J.H., Moon C., Park S.H., Kim S.H., Shin D.H., Park S.C., Kim J.C. Antiinflammatory and antioxidant effects of aqueous extract from Phellinus gilvus in rats. J. Health Sci. 2011, 57:171-176.